BACKGROUND: Previous studies have reported a favorable outcome of patients with normal single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The aim of this study was to assess the very long-term prognosis of patients with known coronary artery disease (CAD) and normal SPECT MPI results. METHODS: The population consisted of 266 patients with known CAD (defined as a healed myocardial infarction and/or a previous coronary revascularization), who underwent exercise bicycle or dobutamine-atropine stress SPECT MPI and had normal perfusion during stress and at rest. End points during follow-up were all-cause mortality, cardiac mortality, and nonfatal myocardial infarction. Univariate and multivariate analyses were performed to identify predictors of long-term outcome. RESULTS: Follow-up was completed in 261 (98%) patients. During a median follow-up of 12 years, 94 (36%) patients died, of which 26 (10%) died due to cardiac causes, and 15 (6%) had a nonfatal myocardial infarction. The annualized mortality rate was 3.1%, annualized cardiac mortality rate was 0.9%, and the annualized event rate for cardiac death and/or nonfatal infarction was 1.2%. Independent predictors of total mortality were age, diabetes mellitus, and rate-pressure product at peak stress. Independent predictors of cardiac mortality were age, male gender, and rate-pressure product at peak stress. CONCLUSION: Patients with known CAD and a normal SPECT MPI study have a favorable long-term prognosis. Clinical and stress test variables can be used to identify patients with a higher risk status.
BACKGROUND: Previous studies have reported a favorable outcome of patients with normal single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI). The aim of this study was to assess the very long-term prognosis of patients with known coronary artery disease (CAD) and normal SPECT MPI results. METHODS: The population consisted of 266 patients with known CAD (defined as a healed myocardial infarction and/or a previous coronary revascularization), who underwent exercise bicycle or dobutamine-atropine stress SPECT MPI and had normal perfusion during stress and at rest. End points during follow-up were all-cause mortality, cardiac mortality, and nonfatal myocardial infarction. Univariate and multivariate analyses were performed to identify predictors of long-term outcome. RESULTS: Follow-up was completed in 261 (98%) patients. During a median follow-up of 12 years, 94 (36%) patients died, of which 26 (10%) died due to cardiac causes, and 15 (6%) had a nonfatal myocardial infarction. The annualized mortality rate was 3.1%, annualized cardiac mortality rate was 0.9%, and the annualized event rate for cardiac death and/or nonfatal infarction was 1.2%. Independent predictors of total mortality were age, diabetes mellitus, and rate-pressure product at peak stress. Independent predictors of cardiac mortality were age, male gender, and rate-pressure product at peak stress. CONCLUSION:Patients with known CAD and a normal SPECT MPI study have a favorable long-term prognosis. Clinical and stress test variables can be used to identify patients with a higher risk status.
Authors: Rory Hachamovitch; Sean Hayes; John D Friedman; Ishac Cohen; Leslee J Shaw; Guido Germano; Daniel S Berman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: A F L Schinkel; J J Bax; M L Geleijnse; E Boersma; A Elhendy; J R T C Roelandt; D Poldermans Journal: Eur Heart J Date: 2003-05 Impact factor: 29.983
Authors: Louise D Metz; Mary Beattie; Robert Hom; Rita F Redberg; Deborah Grady; Kirsten E Fleischmann Journal: J Am Coll Cardiol Date: 2006-12-29 Impact factor: 24.094
Authors: Arend F L Schinkel; Abdou Elhendy; Ron T van Domburg; Jeroen J Bax; Eleni C Vourvouri; Manos Bountioukos; Vittoria Rizzello; Eustachio Agricola; Roelf Valkema; Jos R T C Roelandt; Don Poldermans Journal: Am J Cardiol Date: 2003-02-15 Impact factor: 2.778
Authors: Leslee J Shaw; Robert Hendel; Salvador Borges-Neto; Michael S Lauer; Naomi Alazraki; Joy Burnette; Elizabeth Krawczynska; Manuel Cerqueira; Jamshid Maddahi Journal: J Nucl Med Date: 2003-02 Impact factor: 10.057
Authors: Arend F L Schinkel; Abdou Elhendy; Ron T van Domburg; Jeroen J Bax; Jos R T C Roelandt; Don Poldermans Journal: J Nucl Med Date: 2002-06 Impact factor: 10.057
Authors: Rine Nakanishi; Heidi Gransar; Piotr Slomka; Reza Arsanjani; Aryeh Shalev; Yuka Otaki; John D Friedman; Sean W Hayes; Louise E B Thomson; Mathews Fish; Guido Germano; Aiden Abidov; Leslee Shaw; Alan Rozanski; Daniel S Berman Journal: J Nucl Cardiol Date: 2015-05-14 Impact factor: 5.952
Authors: Jorge Daniel Oldan; Linda K Shaw; Paul Hofmann; Matthew Phelan; Jeffrey Nelson; Robert Pagnanelli; Salvador Borges-Neto Journal: J Nucl Cardiol Date: 2015-06-27 Impact factor: 5.952
Authors: Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti Journal: Arq Bras Cardiol Date: 2020-02 Impact factor: 2.000